NCT06508463 2026-03-16Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell LymphomaMayo ClinicPhase 1 Recruiting21 enrolled
NCT03017820 2025-10-08A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or LymphomaMayo ClinicPhase 1 Recruiting127 enrolled
NCT04781855 2025-02-28Ipilimumab, Ibrutinib, and Nivolumab for the Treatment of Chronic Lymphocytic Leukemia and Richter TransformationM.D. Anderson Cancer CenterPhase 1 Withdrawn
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT01769222 2024-01-24Ipilimumab and Local Radiation for Selected Solid TumorsStanford UniversityPhase 1 Terminated3 enrolled 5 charts